Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study - Potere, N; Di Nisio, M; Cibelli, D (Ann Rheum Dis, 2020)
annrheumdis-2020-218243